Myopathy with rhabdomyolysis as an adverse effect of simultaneous treatment with cerivastatin and gemfibrozil;Miopatija s rabdomiolizom kao nuspojava istodobnog liječenja cerivastatinom i gemfibrozilom

Lijecnicki Vjesnik

Volumn 124, Issue 3-4, 2002, Pages 73-76

  Huić, Mirjana ^a   Anić, Branimir ^a   Čikeš, Nada ^a   Bosnić, Dubravka ^a   Sentić, Mirna ^a   Markeljević, Jasenka ^a   Mayer, Miroslav ^a   Pažanin, Leo ^a  

^a KBC Zagreb   (Croatia)

Author keywords

Antilipemic agents adverse effects; Gemfibrozil adverse effects; Hydroxymethylglutaryl COA reductase inhibitors adverse effects; Muscular diseases chemically induced; Pyridines adverse effects; Rhabdomyolisis chemically induced

Indexed keywords

ANTILIPEMIC AGENT; CERIVASTATIN; GEMFIBROZIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PYRIDINE DERIVATIVE;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG USE; HUMAN; MYOPATHY; RHABDOMYOLYSIS; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

AGED; ANTILIPEMIC AGENTS; DRUG INTERACTIONS; FEMALE; GEMFIBROZIL; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MUSCULAR DISEASES; PYRIDINES; RHABDOMYOLYSIS;

EID: 0036084614     PISSN: 00243477     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Proximal weakness of unknown etiology
2. Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy
3. Possible increased risk of rhabdomyolysis during concomitant use of simvastatin and gemfibrozil
4. Gemfibrozil-induced myopathy
5. Rhabdomyolysis due to cerivastatin monotherapy
6. Acute rhabdomyolysis associated with cerivastatin therapy
7. Cerivastatin-induced rhabdomyolysis
8. Rhabdomyolysis in a patient receiving the combination of cerivastatin and gemfibrozil
9. Rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy
10. A case with severe rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy - A case report
11. Rhabdomyolysis due to combination therapy with cerivastatin and gemfibrozil
12. Rhabdomyolysis after cerivastatin-gemfibrozil therapy in HIV-infected patient with proteinase inhibitor related hyperlilidaemia
13. Drugs affecting lipid metabolism
14. HMG-CoA reductase inhibitors for treatment of hypercholesterolaemia